$NGSX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NeurogesX Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NeurogesX Inc. Get notifications about new insider transactions in NeurogesX Inc for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 7.28 | 33,700 | 245,279 | 686,746 | 653 K to 686.7 K (+5.16 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 7.26 | 43,700 | 317,188 | 2,618,107 | 2.6 M to 2.6 M (+1.70 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 7.25 | 19,795 | 143,522 | 2,574,407 | 2.6 M to 2.6 M (+0.77 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 7.21 | 21,000 | 151,337 | 2,554,612 | 2.5 M to 2.6 M (+0.83 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 7.24 | 704 | 5,095 | 2,533,612 | 2.5 M to 2.5 M (+0.03 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 7.23 | 9,547 | 69,014 | 2,532,908 | 2.5 M to 2.5 M (+0.38 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 7.21 | 13,152 | 94,861 | 2,523,361 | 2.5 M to 2.5 M (+0.52 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 7.25 | 2,000 | 14,490 | 2,510,209 | 2.5 M to 2.5 M (+0.08 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 7.06 | 5,521 | 38,995 | 653,046 | 647.5 K to 653 K (+0.85 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 7.09 | 6,284 | 44,581 | 2,508,209 | 2.5 M to 2.5 M (+0.25 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 7.15 | 4,422 | 31,597 | 2,501,925 | 2.5 M to 2.5 M (+0.18 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 7.18 | 2,199 | 15,797 | 2,497,503 | 2.5 M to 2.5 M (+0.09 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 7.18 | 7,200 | 51,693 | 2,495,304 | 2.5 M to 2.5 M (+0.29 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 7.09 | 8,768 | 62,144 | 2,488,104 | 2.5 M to 2.5 M (+0.35 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 7.10 | 1,300 | 9,229 | 2,479,336 | 2.5 M to 2.5 M (+0.05 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 7.10 | 209 | 1,484 | 2,478,036 | 2.5 M to 2.5 M (+0.01 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 7.08 | 9,800 | 69,348 | 2,477,827 | 2.5 M to 2.5 M (+0.40 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 7.09 | 3,736 | 26,473 | 2,468,027 | 2.5 M to 2.5 M (+0.15 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 7.09 | 2,500 | 17,730 | 647,525 | 645 K to 647.5 K (+0.39 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 7.66 | 5,000 | 38,318 | 645,025 | 640 K to 645 K (+0.78 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 7.81 | 2,400 | 18,735 | 640,025 | 637.6 K to 640 K (+0.38 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 7.60 | 2,500 | 19,011 | 637,625 | 635.1 K to 637.6 K (+0.39 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 7.37 | 3,100 | 22,847 | 635,125 | 632 K to 635.1 K (+0.49 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 7.82 | 3,600 | 28,138 | 632,025 | 628.4 K to 632 K (+0.57 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 7.79 | 5,600 | 43,647 | 628,425 | 622.8 K to 628.4 K (+0.90 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 7.76 | 8,000 | 62,073 | 622,825 | 614.8 K to 622.8 K (+1.30 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 7.44 | 10,000 | 74,448 | 614,825 | 604.8 K to 614.8 K (+1.65 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 7.55 | 7,600 | 57,363 | 604,825 | 597.2 K to 604.8 K (+1.27 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 7.53 | 8,000 | 60,224 | 597,225 | 589.2 K to 597.2 K (+1.36 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 7.89 | 35,000 | 276,290 | 589,225 | 554.2 K to 589.2 K (+6.32 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 8.31 | 7,000 | 58,197 | 554,225 | 547.2 K to 554.2 K (+1.28 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 8.31 | 7,600 | 63,142 | 547,225 | 539.6 K to 547.2 K (+1.41 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 8.07 | 20,000 | 161,458 | 539,625 | 519.6 K to 539.6 K (+3.85 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 8.71 | 13,600 | 118,504 | 519,625 | 506 K to 519.6 K (+2.69 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 8.41 | 15,000 | 126,192 | 506,025 | 491 K to 506 K (+3.05 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 8.30 | 53,000 | 439,651 | 491,025 | 438 K to 491 K (+12.10 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 8.51 | 36,323 | 309,094 | 438,025 | 401.7 K to 438 K (+9.04 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 8.00 | 617,400 | 4,939,138 | 2,464,291 | 1.8 M to 2.5 M (+33.43 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 8.01 | 81,600 | 653,616 | 1,846,891 | 1.8 M to 1.8 M (+4.62 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 7.91 | 87,000 | 688,170 | 1,765,291 | 1.7 M to 1.8 M (+5.18 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 7.69 | 88,000 | 676,720 | 401,702 | 313.7 K to 401.7 K (+28.05 %) |
Jul 29 2010 | NGSX | NeurogesX Inc | Arkin Moshe | 10% Owner | Buy | P | 7.71 | 294,000 | 2,266,740 | 1,678,291 | 1.4 M to 1.7 M (+21.24 %) |
Jun 09 2010 | NGSX | NeurogesX Inc | Goodwin Bradford S | Director | Buy | P | 7.18 | 4,000 | 28,726 | 10,000 | 6 K to 10 K (+66.67 %) |
Jun 09 2010 | NGSX | NeurogesX Inc | Goodwin Bradford S | Director | Buy | P | 7.33 | 6,000 | 44,009 | 6,000 | 0 to 6 K |
Jun 04 2010 | NGSX | NeurogesX Inc | Goodwin Bradford S | Director | Option Exercise | A | 7.79 | 10,000 | 77,900 | 10,000 | |
Jun 04 2010 | NGSX | NeurogesX Inc | Orwin John A | Director | Option Exercise | A | 7.79 | 10,000 | 77,900 | 10,000 | |
Jun 04 2010 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Option Exercise | A | 7.79 | 15,000 | 116,850 | 15,000 | |
Jun 04 2010 | NGSX | NeurogesX Inc | Kurtz Neil M | Director | Option Exercise | A | 7.79 | 10,000 | 77,900 | 10,000 | |
Jun 04 2010 | NGSX | NeurogesX Inc | NELSEN ROBERT | Director | Option Exercise | A | 7.79 | 10,000 | 77,900 | 10,000 | |
May 26 2010 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Sell | S | 8.07 | 1,000 | 8,070 | 10,121 | 11.1 K to 10.1 K (-8.99 %) |
May 26 2010 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Sell | S | 8.06 | 800 | 6,449 | 11,121 | 11.9 K to 11.1 K (-6.71 %) |
May 26 2010 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Sell | S | 8.06 | 200 | 1,612 | 11,921 | 12.1 K to 11.9 K (-1.65 %) |
May 21 2010 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Sell | S | 8.71 | 1,500 | 13,065 | 12,121 | 13.6 K to 12.1 K (-11.01 %) |
May 05 2010 | NGSX | NeurogesX Inc | SVLSF IV, LLC | 10% Owner | Sell | S | 10.25 | 8,282 | 84,891 | 61,324 | 69.6 K to 61.3 K (-11.90 %) |
May 05 2010 | NGSX | NeurogesX Inc | SVLSF IV, LLC | 10% Owner | Sell | S | 10.25 | 291,718 | 2,990,110 | 2,159,991 | 2.5 M to 2.2 M (-11.90 %) |
Mar 02 2010 | NGSX | NeurogesX Inc | Bley Keith R | SVP, Nonclinical R ... | Option Exercise | A | 7.47 | 20,000 | 149,400 | 20,000 | |
Mar 02 2010 | NGSX | NeurogesX Inc | Rinne Susan P | Vice President, Reg ... | Option Exercise | A | 7.47 | 20,000 | 149,400 | 20,000 | |
Mar 02 2010 | NGSX | NeurogesX Inc | Kawahata Russell T | VP, Pharmaceutical ... | Option Exercise | A | 7.47 | 20,000 | 149,400 | 20,000 | |
Jan 19 2010 | NGSX | NeurogesX Inc | DiTonno Anthony A | President, CEO and ... | Option Exercise | A | 7.10 | 12,921 | 91,739 | 12,921 | |
Jan 19 2010 | NGSX | NeurogesX Inc | DiTonno Anthony A | President, CEO and ... | Option Exercise | A | 7.10 | 80,000 | 568,000 | 80,000 | |
Jan 19 2010 | NGSX | NeurogesX Inc | Tobias Jeffrey K | Chief Medical Offic ... | Option Exercise | A | 7.10 | 50,000 | 355,000 | 50,000 | |
Jan 19 2010 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Chief Financial Off ... | Option Exercise | A | 7.10 | 5,457 | 38,745 | 5,457 | |
Jan 19 2010 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Chief Financial Off ... | Option Exercise | A | 7.10 | 60,000 | 426,000 | 60,000 | |
Jan 19 2010 | NGSX | NeurogesX Inc | Markels Michael | VP, Commercial Ops ... | Option Exercise | A | 7.10 | 3,661 | 25,993 | 3,661 | |
Jan 19 2010 | NGSX | NeurogesX Inc | Markels Michael | VP, Commercial Ops ... | Option Exercise | A | 7.10 | 30,000 | 213,000 | 30,000 | |
Jan 08 2010 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Chief Financial Off ... | Gift | G | 0.00 | 810 | 0 | 3,026 | 3.8 K to 3 K (-21.12 %) |
Jan 08 2010 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Chief Financial Off ... | Gift | G | 0.00 | 540 | 0 | 3,836 | 4.4 K to 3.8 K (-12.34 %) |
Dec 07 2009 | NGSX | NeurogesX Inc | Bley Keith R | SVP Nonclinical R & ... | Option Exercise | A | 8.32 | 1,000 | 8,320 | 1,000 | |
Dec 07 2009 | NGSX | NeurogesX Inc | DiTonno Anthony A | President, CEO and ... | Option Exercise | A | 8.32 | 1,000 | 8,320 | 1,000 | |
Dec 07 2009 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Chief Financial Off ... | Option Exercise | A | 8.32 | 1,000 | 8,320 | 1,000 | |
Dec 07 2009 | NGSX | NeurogesX Inc | Rinne Susan P | Vice President, Reg ... | Option Exercise | A | 8.32 | 1,000 | 8,320 | 1,000 | |
Dec 07 2009 | NGSX | NeurogesX Inc | Tobias Jeffrey K | Chief Medical Offic ... | Option Exercise | A | 8.32 | 1,000 | 8,320 | 1,000 | |
Dec 07 2009 | NGSX | NeurogesX Inc | Markels Michael | VP, Commercial Ops ... | Option Exercise | A | 8.32 | 1,000 | 8,320 | 1,000 | |
Dec 07 2009 | NGSX | NeurogesX Inc | Kawahata Russell T | V P, Pharmaceutical ... | Option Exercise | A | 8.32 | 1,000 | 8,320 | 1,000 | |
Dec 01 2009 | NGSX | NeurogesX Inc | Tobias Jeffrey K | Chief Medical Offic ... | Option Exercise | M | 1.25 | 12,077 | 15,096 | 38,000 | |
Dec 01 2009 | NGSX | NeurogesX Inc | Tobias Jeffrey K | Chief Medical Offic ... | Sell | S | 8.07 | 12,077 | 97,494 | 6,665 | 18.7 K to 6.7 K (-64.44 %) |
Dec 01 2009 | NGSX | NeurogesX Inc | Tobias Jeffrey K | Chief Medical Offic ... | Buy | M | 1.25 | 12,077 | 15,096 | 18,742 | 6.7 K to 18.7 K (+181.20 %) |
Nov 30 2009 | NGSX | NeurogesX Inc | Tobias Jeffrey K | Chief Medical Offic ... | Option Exercise | M | 1.25 | 620 | 775 | 50,077 | |
Nov 30 2009 | NGSX | NeurogesX Inc | Tobias Jeffrey K | Chief Medical Offic ... | Option Exercise | M | 1.25 | 9,303 | 11,629 | 50,697 | |
Nov 30 2009 | NGSX | NeurogesX Inc | Tobias Jeffrey K | Chief Medical Offic ... | Sell | S | 8.27 | 620 | 5,130 | 6,665 | 7.3 K to 6.7 K (-8.51 %) |
Nov 30 2009 | NGSX | NeurogesX Inc | Tobias Jeffrey K | Chief Medical Offic ... | Buy | M | 1.25 | 620 | 775 | 7,285 | 6.7 K to 7.3 K (+9.30 %) |
Nov 30 2009 | NGSX | NeurogesX Inc | Tobias Jeffrey K | Chief Medical Offic ... | Sell | S | 8.38 | 9,303 | 77,976 | 6,665 | 16 K to 6.7 K (-58.26 %) |
Nov 30 2009 | NGSX | NeurogesX Inc | Tobias Jeffrey K | Chief Medical Offic ... | Buy | M | 1.25 | 9,303 | 11,629 | 15,968 | 6.7 K to 16 K (+139.58 %) |
Nov 23 2009 | NGSX | NeurogesX Inc | Orwin John A | Director | Option Exercise | A | 8.38 | 20,000 | 167,600 | 20,000 | |
Nov 23 2009 | NGSX | NeurogesX Inc | Rinne Susan P | Vice President, Reg ... | Option Exercise | A | 8.38 | 25,000 | 209,500 | 25,000 | |
Nov 23 2009 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Sell | S | 8.45 | 712 | 6,016 | 13,621 | 14.3 K to 13.6 K (-4.97 %) |
Nov 23 2009 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Sell | S | 8.44 | 620 | 5,233 | 14,333 | 15 K to 14.3 K (-4.15 %) |
Nov 23 2009 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Sell | S | 8.43 | 100 | 843 | 14,953 | 15.1 K to 15 K (-0.66 %) |
Nov 23 2009 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Sell | S | 8.40 | 568 | 4,773 | 15,053 | 15.6 K to 15.1 K (-3.64 %) |
Nov 23 2009 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Sell | S | 8.26 | 700 | 5,782 | 15,621 | 16.3 K to 15.6 K (-4.29 %) |
Nov 23 2009 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Sell | S | 8.25 | 800 | 6,600 | 16,321 | 17.1 K to 16.3 K (-4.67 %) |
Nov 23 2009 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Sell | S | 8.23 | 500 | 4,116 | 17,121 | 17.6 K to 17.1 K (-2.84 %) |
Nov 23 2009 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Sell | S | 8.16 | 300 | 2,448 | 17,621 | 17.9 K to 17.6 K (-1.67 %) |
Nov 23 2009 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Sell | S | 8.15 | 1,450 | 11,818 | 17,921 | 19.4 K to 17.9 K (-7.49 %) |
Nov 23 2009 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Sell | S | 8.15 | 250 | 2,038 | 19,371 | 19.6 K to 19.4 K (-1.27 %) |
Oct 19 2009 | NGSX | NeurogesX Inc | NELSEN ROBERT | Director | Option Exercise | A | 8.08 | 5,000 | 40,400 | 20,000 | |
Oct 19 2009 | NGSX | NeurogesX Inc | Kurtz Neil M | Director | Option Exercise | A | 8.08 | 5,000 | 40,400 | 30,666 | |
Oct 19 2009 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Option Exercise | A | 8.08 | 10,000 | 80,800 | 36,333 | |
Sep 17 2009 | NGSX | NeurogesX Inc | SVLSF IV, LLC | 10% Owner | Sell | S | 8.05 | 3 | 24 | 69,606 | 69.6 K to 69.6 K (0.00 %) |
Sep 17 2009 | NGSX | NeurogesX Inc | SVLSF IV, LLC | 10% Owner | Sell | S | 8.05 | 97 | 781 | 2,451,709 | 2.5 M to 2.5 M (0.00 %) |
Sep 17 2009 | NGSX | NeurogesX Inc | SVLSF IV, LLC | 10% Owner | Sell | S | 8.05 | 100 | 805 | 2,521,315 | 2.5 M to 2.5 M (0.00 %) |
Sep 17 2009 | NGSX | NeurogesX Inc | SVLSF IV, LLC | 10% Owner | Sell | S | 8.05 | 100 | 805 | 2,521,315 | 2.5 M to 2.5 M (0.00 %) |
Sep 17 2009 | NGSX | NeurogesX Inc | SVLSF IV, LLC | 10% Owner | Sell | S | 8.00 | 16,975 | 135,800 | 69,609 | 86.6 K to 69.6 K (-19.61 %) |
Sep 17 2009 | NGSX | NeurogesX Inc | SVLSF IV, LLC | 10% Owner | Sell | S | 8.00 | 597,925 | 4,783,400 | 2,451,806 | 3 M to 2.5 M (-19.61 %) |
Sep 17 2009 | NGSX | NeurogesX Inc | SVLSF IV, LLC | 10% Owner | Sell | S | 8.00 | 614,900 | 4,919,200 | 2,521,415 | 3.1 M to 2.5 M (-19.61 %) |
Sep 17 2009 | NGSX | NeurogesX Inc | SVLSF IV, LLC | 10% Owner | Sell | S | 8.00 | 614,900 | 4,919,200 | 2,521,415 | 3.1 M to 2.5 M (-19.61 %) |
Aug 21 2009 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Sell | S | 7.23 | 100 | 723 | 19,621 | 19.7 K to 19.6 K (-0.51 %) |
Aug 21 2009 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Sell | S | 7.22 | 900 | 6,498 | 19,721 | 20.6 K to 19.7 K (-4.36 %) |
Aug 24 2009 | NGSX | NeurogesX Inc | Goodwin Bradford S | Director | Option Exercise | A | 7.25 | 20,000 | 145,000 | 20,000 | |
Aug 17 2009 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Sell | S | 7.35 | 619 | 4,550 | 20,621 | 21.2 K to 20.6 K (-2.91 %) |
Aug 17 2009 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Sell | S | 7.26 | 359 | 2,606 | 21,240 | 21.6 K to 21.2 K (-1.66 %) |
Aug 17 2009 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Sell | S | 7.25 | 641 | 4,647 | 21,599 | 22.2 K to 21.6 K (-2.88 %) |
Aug 17 2009 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Sell | S | 7.23 | 100 | 723 | 22,240 | 22.3 K to 22.2 K (-0.45 %) |
Aug 17 2009 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Sell | S | 7.22 | 1,400 | 10,108 | 22,340 | 23.7 K to 22.3 K (-5.90 %) |
Aug 17 2009 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Sell | S | 7.21 | 1,000 | 7,210 | 23,740 | 24.7 K to 23.7 K (-4.04 %) |
Aug 17 2009 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Sell | S | 7.29 | 1,621 | 11,811 | 24,740 | 26.4 K to 24.7 K (-6.15 %) |
Aug 17 2009 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Sell | S | 7.18 | 1,000 | 7,180 | 26,361 | 27.4 K to 26.4 K (-3.65 %) |
Aug 14 2009 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Sell | S | 7.10 | 500 | 3,550 | 27,361 | 27.9 K to 27.4 K (-1.79 %) |
Aug 14 2009 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Sell | S | 7.30 | 1,500 | 10,950 | 27,861 | 29.4 K to 27.9 K (-5.11 %) |
Aug 14 2009 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Sell | S | 7.27 | 179 | 1,301 | 29,361 | 29.5 K to 29.4 K (-0.61 %) |
Aug 14 2009 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Sell | S | 7.21 | 500 | 3,605 | 29,540 | 30 K to 29.5 K (-1.66 %) |
Aug 14 2009 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Sell | S | 7.20 | 500 | 3,600 | 30,040 | 30.5 K to 30 K (-1.64 %) |
Aug 14 2009 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Sell | S | 7.61 | 500 | 3,805 | 30,540 | 31 K to 30.5 K (-1.61 %) |
Aug 14 2009 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Sell | S | 7.60 | 1,500 | 11,400 | 31,040 | 32.5 K to 31 K (-4.61 %) |
Aug 14 2009 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Sell | S | 7.52 | 482 | 3,625 | 32,540 | 33 K to 32.5 K (-1.46 %) |
Jul 30 2009 | NGSX | NeurogesX Inc | DiTonno Anthony A | President, CEO and ... | Option Exercise | A | 8.50 | 35,000 | 297,500 | 35,000 | |
Jul 30 2009 | NGSX | NeurogesX Inc | Markels Michael | VP, Commercial Ops ... | Option Exercise | A | 8.50 | 30,000 | 255,000 | 30,000 | |
Jul 30 2009 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Chief Financial Off ... | Option Exercise | A | 8.50 | 20,000 | 170,000 | 20,000 | |
Jul 15 2009 | NGSX | NeurogesX Inc | Flynn James E | 10% Owner | Sell | S | 5.97 | 162,600 | 970,722 | 987,880 | 1.2 M to 987.9 K (-14.13 %) |
Jul 15 2009 | NGSX | NeurogesX Inc | Flynn James E | 10% Owner | Sell | S | 5.97 | 87,552 | 522,685 | 537,701 | 625.3 K to 537.7 K (-14.00 %) |
Jul 10 2009 | NGSX | NeurogesX Inc | Flynn James E | 10% Owner | Sell | S | 5.97 | 6,501 | 38,811 | 1,150,480 | 1.2 M to 1.2 M (-0.56 %) |
Jul 10 2009 | NGSX | NeurogesX Inc | Flynn James E | 10% Owner | Sell | S | 5.97 | 3,499 | 20,889 | 625,253 | 628.8 K to 625.3 K (-0.56 %) |
Jul 10 2009 | NGSX | NeurogesX Inc | Flynn James E | 10% Owner | Sell | S | 5.89 | 8,902 | 52,433 | 1,156,981 | 1.2 M to 1.2 M (-0.76 %) |
Jul 10 2009 | NGSX | NeurogesX Inc | Flynn James E | 10% Owner | Sell | S | 5.89 | 4,792 | 28,225 | 628,752 | 633.5 K to 628.8 K (-0.76 %) |
Jul 08 2009 | NGSX | NeurogesX Inc | Flynn James E | 10% Owner | Sell | S | 5.96 | 19,404 | 115,648 | 1,165,883 | 1.2 M to 1.2 M (-1.64 %) |
Jul 08 2009 | NGSX | NeurogesX Inc | Flynn James E | 10% Owner | Sell | S | 5.96 | 10,447 | 62,264 | 633,544 | 644 K to 633.5 K (-1.62 %) |
Jul 08 2009 | NGSX | NeurogesX Inc | Flynn James E | 10% Owner | Sell | S | 5.90 | 15,990 | 94,341 | 1,185,287 | 1.2 M to 1.2 M (-1.33 %) |
Jul 08 2009 | NGSX | NeurogesX Inc | Flynn James E | 10% Owner | Sell | S | 5.90 | 8,609 | 50,793 | 643,991 | 652.6 K to 644 K (-1.32 %) |
Jul 01 2009 | NGSX | NeurogesX Inc | Flynn James E | 10% Owner | Sell | S | 5.99 | 10,247 | 61,380 | 1,201,277 | 1.2 M to 1.2 M (-0.85 %) |
Jul 01 2009 | NGSX | NeurogesX Inc | Flynn James E | 10% Owner | Sell | S | 5.99 | 5,517 | 33,047 | 652,600 | 658.1 K to 652.6 K (-0.84 %) |
Jul 01 2009 | NGSX | NeurogesX Inc | Flynn James E | 10% Owner | Sell | S | 5.86 | 164,444 | 963,642 | 1,211,524 | 1.4 M to 1.2 M (-11.95 %) |
Jul 01 2009 | NGSX | NeurogesX Inc | Flynn James E | 10% Owner | Sell | S | 5.86 | 3,745 | 21,946 | 1,375,968 | 1.4 M to 1.4 M (-0.27 %) |
Jul 01 2009 | NGSX | NeurogesX Inc | Flynn James E | 10% Owner | Sell | S | 5.86 | 89,327 | 523,456 | 658,117 | 747.4 K to 658.1 K (-11.95 %) |
Jul 01 2009 | NGSX | NeurogesX Inc | Flynn James E | 10% Owner | Sell | S | 5.86 | 2,033 | 11,913 | 747,444 | 749.5 K to 747.4 K (-0.27 %) |
Jun 25 2009 | NGSX | NeurogesX Inc | Flynn James E | 10% Owner | Sell | S | 5.87 | 1,519 | 8,917 | 1,379,713 | 1.4 M to 1.4 M (-0.11 %) |
Jun 25 2009 | NGSX | NeurogesX Inc | Flynn James E | 10% Owner | Sell | S | 5.73 | 6,035 | 34,581 | 1,381,232 | 1.4 M to 1.4 M (-0.44 %) |
Jun 25 2009 | NGSX | NeurogesX Inc | Flynn James E | 10% Owner | Sell | S | 5.87 | 825 | 4,843 | 749,477 | 750.3 K to 749.5 K (-0.11 %) |
Jun 25 2009 | NGSX | NeurogesX Inc | Flynn James E | 10% Owner | Sell | S | 5.73 | 3,278 | 18,783 | 750,302 | 753.6 K to 750.3 K (-0.43 %) |
Jun 25 2009 | NGSX | NeurogesX Inc | Flynn James E | 10% Owner | Sell | S | 6.08 | 3,305 | 20,094 | 1,387,267 | 1.4 M to 1.4 M (-0.24 %) |
Jun 25 2009 | NGSX | NeurogesX Inc | Flynn James E | 10% Owner | Sell | S | 6.10 | 16,200 | 98,820 | 1,390,572 | 1.4 M to 1.4 M (-1.15 %) |